Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Recent & Breaking News (GREY:IMVIQ)

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets

Business Wire September 1, 2023

IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

Business Wire July 26, 2023

IMV Receives NASDAQ Delisting Notice

Business Wire May 8, 2023

Horizon Technology Finance Announces First Quarter 2023 Financial Results

PR Newswire May 2, 2023

IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives

Business Wire May 1, 2023

IIROC Trading Halt - IMV

Canada NewsWire May 1, 2023

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Business Wire March 31, 2023

IMV Inc. Announces Changes to Its Board of Directors

Business Wire March 27, 2023

IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results

Business Wire March 16, 2023

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

Business Wire March 9, 2023

IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial

Business Wire February 13, 2023

IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S

Business Wire January 8, 2023

IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Business Wire December 20, 2022

IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Business Wire December 16, 2022

IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL

Business Wire December 15, 2022

IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split

Business Wire December 13, 2022

IMV Shareholders Approve Reverse Stock Split at 88%

Business Wire December 7, 2022

IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities

Business Wire November 25, 2022

IMV Inc. Announces Third Quarter 2022 Financial and Operational Results

Business Wire November 10, 2022

IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022

Business Wire November 8, 2022